NASDAQ:MGX | Balance Sheet | Metagenomi Therapeutics, Inc.

Complete source-backed balance-sheet history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$39.03M$0.00$124.47M$9.9M$1.02M$173.7M$2.6M$27.63M$2.02M$61.13M$112.57M
2026-03-31$25.31M$0.00$144.56M$11.16M$927,000.00$196.95M$2.4M$22.5M$1.95M$59.17M$137.79M
2025-12-31$41.72M$305,000.00$165.54M$12.29M$836,000.00$221.1M$1.49M$22.93M$1.95M$62.51M$158.6M
2025-09-30$32.77M$189.82M$13.9M$809,000.00$247.94M$1.22M$29.58M$1.92M$69.49M$178.45M
2025-06-30$26.85M$900,000.00$211.68M$15.11M$805,000.00$272.28M$2.89M$33.27M$2.15M$76.45M$195.83M
2025-03-31$29.2M$900,000.00$233.2M$16.52M$781,000.00$297.87M$2.67M$39.89M$2.11M$85.21M$212.66M
2024-12-31$27.39M$1.1M$257.96M$17.74M$287,000.00$324.6M$533,000.00$37.31M$2.01M$89.74M$234.86M
2024-09-30$25.12M$282.29M$19.72M$320,000.00$358.35M$3.1M$45.69M$3.08M$102.58M$255.77M
2024-06-30$61.18M$307.58M$20.71M$332,000.00$385.91M$3.45M$52.81M$3.8M$116.49M$269.42M
2024-03-31$102.56M$335.64M$20.96M$379,000.00$415.4M$6.84M$70.7M$5.08M$139.77M$275.63M
2023-12-31$140.6M$278.27M$21.54M$5.49M$364.84M$1.79M$68.86M$5.08M$149.67M-$135.58M
2023-09-30$101.9M-$119,021.00
2023-06-30$51.65M-$102.54M
2023-03-31$95.67M-$90.01M
2022-12-31$190.51M-$74.43M